We cannot conclude that adipolin and adiponectin are significantly involved in the pathogenesis of GDM or can be used as a biomarker of GDM in pregnant women with pregestational overweight or obesity. This evidence concerns the gene C1QTNF12 and obesity due to melanocortin 4 receptor deficiency.